Emedastine cost-effective therapy in allergic conjunctivitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 311, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries

By Ghatnekar O.   Persson U.   Willis M.   Odegaard K.  

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 767-778

Adis International

Access to resources Recommend Favorite

Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle Glaucoma: In Four European Countries

By Rouland J.  

PharmacoEconomics, Vol. 21, Iss. 3, 2003-01 ,pp. : 201-213

Adis International

Access to resources Recommend Favorite

Onset and Duration of Action of Ketotifen 0.025% and Emedastine 0.05% in Seasonal Allergic Conjunctivitis: Efficacy after Repeated Pollen Challenges in the Vienna Challenge Chamber

By Horak F.  

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 329-337

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis

By Nickels Andrew S   Dimov Vesselin   Wolf Raoul  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1593-1599

Informa Healthcare

Access to resources Recommend Favorite